Bitcoin set for a rebound that could stretch toward $100000, BTIG says
HANOI/HOLMDEL - BIO-key International, Inc. (NASDAQ:BKYI) announced Monday a strategic partnership with Vietnam's SAVIS Group to distribute its identity and access management (IAM) solutions throughout Vietnam. The micro-cap company, currently valued at just $6.5 million, is looking to expand its reach in Asian markets while maintaining its impressive 78.4% gross profit margins.
The collaboration will combine BIO-key's biometric authentication platforms with SAVIS Group's expertise in digital trust and enterprise solutions to serve businesses, government agencies, and institutions across Vietnam.
As an authorized distributor, SAVIS Group will integrate and deliver BIO-key's IAM portfolio through its network of solution partners and enterprise customers. The company will provide localized pre-sales, deployment, and technical support services.
Products offered through the partnership include BIO-key's PortalGuard IAM platform, Passkey:YOU passwordless solution, PIN:You authentication method, and various biometric authentication tools.
"This partnership strengthens our portfolio and allows us to deliver cutting-edge security solutions to our clients," said Nhung Rose, Business Development Manager at SAVIS Group, according to the press release.
Naresh Kumar, Channel Director of International Sales at BIO-key, stated the partnership aligns with the company's strategy to expand into Asian markets, while Alex Rocha, Managing Director of International operations, highlighted Vietnam as "one of the most attractive Asian markets."
SAVIS Group specializes in digital signing, identity verification, electronic authentication, and cybersecurity services in Vietnam. BIO-key provides biometric-centric identity and access management software that secures access for over forty million users globally.
The announcement was made in a company press release.
In other recent news, BIO-key International Inc. reported a decline in revenue for the third quarter of 2025, with figures dropping to $1.55 million from $2.1 million in the same period last year. Despite this revenue decrease, the company maintained a strong gross margin and reduced operating expenses, highlighting a focus on financial discipline. These recent developments indicate BIO-key's ongoing efforts to manage costs effectively amid challenging circumstances. The company's financial results reflect a strategic emphasis on maintaining profitability while navigating a decrease in overall revenue. No major mergers or acquisitions were reported for BIO-key during this period. Additionally, there were no analyst upgrades or downgrades mentioned for BIO-key in the recent news. Investors and stakeholders may consider these factors when assessing the company's current financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.